Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LUBIPROSTONE
- Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease
- Lubiprostone for Functional Constipation in the Under 18 Years Patients
- Study of Comparative Effectiveness of Prucalopride and Lubiprostone in Constipation Predominant Irritable Bowel Syndrome
- Colon Preparation With 2L PEG in Combination With Lubiprostone vs 4L PEG
- Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo
- Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers
- Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation
- Lubiprostone for Chronic Idiopathic Constipation Treatment
- Lubiprostone for Treatment of Chronic Idiopathic Constipation
- Lubiprostone for the Treatment of Chronic Idiopathic Constipation
- Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
- A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
- Lubiprostone for Children With Constipation
- Lubiprostone in Children With Functional Constipation
- Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation
- Pilot Study of Lubiprostone as a Modulator of Gut Microbial Translocation and Systemic Immune Activation in HIV-Infected Persons With Incomplete CD4+ T-cell Recovery on Antiretroviral Therapy
- Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation
- Lubiprostone Effect on Gastrointestinal Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation
- Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation
- Lubiprostone and Mucus Secretion in Patients With Chronic Constipation
- Evaluation of Clinical Equivalence Between Two Lubiprostone Products
- Comparative Study of Lubiprostone and PEG Preparation Versus Conventional PEG Preparation for Colonoscopy
- Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)
- Lubiprostone in Patients With Multiple Sclerosis Associated Constipation
- Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation.
- The Effectiveness of Lubiprostone in Constipated Diabetics
- Lubiprostone Effects on Visceral Pain Sensitivity
- Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation
- Comparison of Lubiprostone and Placebo for the Relief of Constipation From Constipating Medications
- Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)
- Lubiprostone, Colonic Motility and Sensation
- Intestinal Microecology in Chronic Constipation
- Amitiza in Constipation Associated With PD (Parkinson's Disease)
- Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit
- Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy
- Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis
- Efficacy of Lubiprostone in Combination With Standard PEG Preparation
- Lubiprostone as a Treatment for Constipation in Parkinson's Disease
- Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation
- Amitiza® Plus GoLYTELY® Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation
- Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
- Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy
- Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
- Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
- Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation
- Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
- Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
Clinical trials list
click for details